Palliative Care for Heart Failure
(ADAPT HF Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different combinations of palliative care, including the ADAPT HF program, can help manage pain in Black adults with advanced heart failure. Participants will be randomly assigned to one of 16 groups, each receiving a unique mix of support such as pain education, self-care tips, communication coaching, and spiritual guidance. Those with advanced heart failure who have experienced pain in the last month and live in certain regions of the southern U.S. may be a good fit. As an unphased trial, this study offers a unique opportunity to contribute to research that could improve pain management strategies for others with similar conditions.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the ADAPT HF treatment, part of a supportive care approach for heart failure, has been generally well-tolerated. For example, one study examined a team-based supportive care plan combined with regular heart failure treatment and found positive results without major safety issues. Another study, involving a nurse and social worker team providing remote care for heart failure patients, also reported improvements in quality of life with no serious side effects.
Additionally, adding supportive care to heart failure treatment is a recommended practice, demonstrating safety and effectiveness. These studies suggest that supportive care treatments like ADAPT HF aim to improve the quality of life for heart failure patients without significant risks. However, it is always important to consider personal health and consult a healthcare provider when considering participation in such trials.12345Why are researchers excited about this trial?
Researchers are excited about these palliative care treatments for heart failure because they emphasize a holistic approach, integrating pain management, self-care, and spirituality. Unlike traditional treatments that focus primarily on medication and physical interventions, these methods aim to support emotional and spiritual well-being, which can significantly enhance quality of life. The unique delivery through telephone coaching and self-guided sessions makes these treatments accessible and adaptable to individual patient needs. This comprehensive approach could provide a more personalized support system, potentially leading to better outcomes for patients living with heart failure.
What evidence suggests that this trial's treatments could be effective for heart failure?
Research has shown that palliative care can greatly improve the quality of life for people with advanced heart failure. The PAL-HF trial found that a team-based palliative care program improved patients' well-being and life satisfaction. Another study found that palliative care reduced hospital visits and improved health outcomes for heart failure patients. This type of care includes help with managing pain, a significant issue for many with heart failure. In this trial, the ADAPT HF program offers various treatment arms, each providing different combinations of sessions led by guides to assist with pain through education, self-care, communication, and spirituality. These combined methods have shown promise in enhancing patient well-being.12678
Are You a Good Fit for This Trial?
This trial is for African American adults over 18 with advanced heart failure who have experienced pain in the last month. They must speak English, be willing to participate in the study and data collection, and live in certain regions of the US (Alabama, Mississippi, Tennessee, Kentucky, Arkansas, Louisiana, Oklahoma, Texas).Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive navigator-led palliative care intervention addressing pain through various components such as pain education, self-care, communication, and spirituality.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 12 and 24 weeks after baseline.
What Are the Treatments Tested in This Trial?
Interventions
- ADAPT HF
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor